Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has shared an update.
Guangzhou Baiyunshan Pharmaceutical Holdings Company, through its subsidiary GP Corp., has engaged in a series of transactions involving the sale of accounts receivable to Industrial Securities Asset Management. The latest transaction, completed on February 28, 2025, involves the disposal of new underlying assets valued at RMB583,087,010.44. This transaction, when aggregated with previous similar transactions within a 12-month period, constitutes a disclosable transaction under Hong Kong’s Listing Rules, requiring reporting and announcement but not shareholder approval.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
YTD Price Performance: 2.40%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.67B
For detailed information about 0874 stock, go to TipRanks’ Stock Analysis page.